Familial Mediterranean fever-associated mutation pyrin E148Q as a potential risk factor for multiple sclerosis

T Kümpfel1, L-A Gerdes, T Wacker

  • 1Institute of Clinical Neuroimmunology - Großhadern, Ludwig-Maximilians University of Munich, Germany. tania.kuempfel@med.uni-muenchen.de

Multiple Sclerosis (Houndmills, Basingstoke, England)
|February 17, 2012
PubMed
Abstract

Insights

Familial Mediterranean fever (FMF) gene mutations, particularly E148Q, may increase multiple sclerosis (MS) susceptibility in Germany. Further research is needed to confirm this association and its implications for MS risk.

Area of Science:

  • Genetics
  • Immunology
  • Neurology

Background:

  • Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder caused by MEFV gene mutations.
  • Previous studies suggest a potential link between FMF and multiple sclerosis (MS) in Turkish and Israeli populations.

Purpose of the Study:

  • To determine the prevalence of MEFV gene mutations in German individuals with MS.
  • To investigate the association between specific MEFV mutations (E148Q, K695R) and MS in a German cohort.

Main Methods:

  • Genotyping of MEFV exons 2, 3, and 10 in 157 MS patients (group 1).
  • Screening for E148Q and K695R mutations in 260 MS patients (group 2) and 400 controls.
  • Analysis of mutation co-segregation with MS in affected families.

Main Results:

  • 12.1% of MS patients in group 1 carried an MEFV mutation, predominantly E148Q.
  • 15 of 19 mutation carriers reported FMF-suggestive symptoms.
  • E148Q mutation showed co-segregation with MS in three families (p=0.026).
  • No significant difference in E148Q/K695R frequencies between MS group 2 and controls, but high prevalence in the German population.

Conclusions:

  • The MEFV gene is a potential contributor to MS susceptibility.
  • The pyrin E148Q mutation is a candidate risk factor for MS, warranting further investigation.
  • The high frequency of MEFV mutations in the German population merits attention.